BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31715544)

  • 1. Candidate single nucleotide polymorphisms and thromboembolism in acute lymphoblastic leukemia - A NOPHO ALL2008 study.
    Jarvis KB; LeBlanc M; Tulstrup M; Nielsen RL; Albertsen BK; Gupta R; Huttunen P; Jónsson ÓG; Rank CU; Ranta S; Ruud E; Saks K; Trakymiene SS; Tuckuviene R; Schmiegelow K
    Thromb Res; 2019 Dec; 184():92-98. PubMed ID: 31715544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous thromboembolism risk associated with ABO, F11 and FGG loci.
    Manco L; Silva C; Fidalgo T; Martinho P; Sarmento AB; Ribeiro ML
    Blood Coagul Fibrinolysis; 2018 Sep; 29(6):528-532. PubMed ID: 29995659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.
    Småbrekke B; Rinde LB; Evensen LH; Morelli VM; Hveem K; Gabrielsen ME; Njølstad I; Mathiesen EB; Rosendaal FR; Braekkan SK; Hansen JB
    J Thromb Haemost; 2019 Aug; 17(8):1363-1371. PubMed ID: 31124268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years.
    Rank CU; Toft N; Tuckuviene R; Grell K; Nielsen OJ; Frandsen TL; Marquart HVH; Albertsen BK; Tedgård U; Hallböök H; Ruud E; Jarvis KB; Quist-Paulsen P; Huttunen P; Wartiovaara-Kautto U; Jónsson ÓG; Trakymiene SS; Griškevičius L; Saks K; Punab M; Schmiegelow K
    Blood; 2018 May; 131(22):2475-2484. PubMed ID: 29661787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polygenic risk score-analysis of thromboembolism in patients with acute lymphoblastic leukemia.
    Jarvis KB; Nielsen RL; Gupta R; Hede FD; Huttunen P; Jónsson ÓG; Rank CU; Ranta S; Saks K; Trakymiene SS; Tuckuviene R; Tulstrup M; ; Ruud E; Schmiegelow K; LeBlanc M
    Thromb Res; 2020 Dec; 196():15-20. PubMed ID: 32818716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study.
    Rinde LB; Morelli VM; Småbrekke B; Mathiesen EB; Løchen ML; Njølstad I; Wilsgaard T; Smith E; Rosendaal FR; Frazer KA; Braekkan SK; Hansen JB
    J Thromb Haemost; 2019 May; 17(5):749-758. PubMed ID: 30773804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective study of thromboembolism in 1038 children with acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology (NOPHO) study.
    Tuckuviene R; Ranta S; Albertsen BK; Andersson NG; Bendtsen MD; Frisk T; Gunnes MW; Helgestad J; Heyman MM; Jonsson OG; Mäkipernaa A; Pruunsild K; Tedgård U; Trakymiene SS; Ruud E
    J Thromb Haemost; 2016 Mar; 14(3):485-94. PubMed ID: 26707629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. F11 is associated with recurrent VTE in women. A prospective cohort study.
    Bruzelius M; Ljungqvist M; Bottai M; Bergendal A; Strawbridge RJ; Holmström M; Silveira A; Kieler H; Hamsten A; Lärfars G; Odeberg J
    Thromb Haemost; 2016 Jan; 115(2):406-14. PubMed ID: 26423325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism.
    Johnsen HS; Bjøri E; Hindberg K; Brækkan SK; Morelli VM; Hansen JB
    Thromb Res; 2020 Jul; 191():82-89. PubMed ID: 32402998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event.
    Skille H; Paulsen B; Hveem K; Gabrielsen ME; Brumpton B; Hindberg K; Gran OV; Rosendaal FR; Braekkan SK; Hansen JB
    J Thromb Haemost; 2020 Nov; 18(11):2861-2869. PubMed ID: 32671915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Risk of Venous Thromboembolism Attributed to Established Prothrombotic Genotypes.
    Evensen LH; Arnesen CAL; Rosendaal FR; Gabrielsen ME; Brumpton BM; Hveem K; Hansen JB; Brækkan SK
    Thromb Haemost; 2022 Jul; 122(7):1221-1230. PubMed ID: 34784644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic Risk Profiling Associated with Recurrent Unprovoked Venous Thromboembolism.
    Hodeib H; Youssef A; Allam AA; Selim A; Tawfik MA; Abosamak MF; Esam A; Abd Elghafar MS; Samir S; ELshora OA
    Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Joint Effect of Multiple Prothrombotic Genotypes and Obesity on the Risk of Incident Venous Thromboembolism.
    Frischmuth T; Hindberg K; Gabrielsen ME; Brumpton B; Hveem K; Brækkan SK; Hansen JB; Morelli VM
    Thromb Haemost; 2022 Feb; 122(2):267-276. PubMed ID: 33940655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joint effects of prothrombotic genotypes and body height on the risk of venous thromboembolism: the Tromsø study.
    Horvei LD; Braekkan SK; Smith EN; Solomon T; Hindberg K; Frazer KA; Rosendaal FR; Hansen JB
    J Thromb Haemost; 2018 Jan; 16(1):83-89. PubMed ID: 29094466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.
    Skille H; Paulsen B; Hveem K; Severinsen MT; Gabrielsen ME; Kristensen SR; Næss IA; Hindberg K; Tjønneland A; Brækkan SK; Hansen JB
    Thromb Res; 2021 Sep; 205():17-23. PubMed ID: 34237679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance therapy and risk of osteonecrosis in children and young adults with acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
    Toksvang LN; Andrés-Jensen L; Rank CU; Niinimäki R; Nersting J; Nielsen SN; Mogensen SS; Harila-Saari A; Abrahamsson J; Joelsson J; Overgaard UM; Quist-Paulsen P; Griškevičius L; Jónsson ÓG; Vaitkevičienė G; Frandsen TL; Toft N; Grell K; Schmiegelow K
    Cancer Chemother Pharmacol; 2021 Nov; 88(5):911-917. PubMed ID: 34145469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint Effect of Multiple Prothrombotic Genotypes and Mean Platelet Volume on the Risk of Incident Venous Thromboembolism.
    Jakobsen L; Frischmuth T; Brækkan SK; Hansen JB; Morelli VM
    Thromb Haemost; 2022 Nov; 122(11):1911-1920. PubMed ID: 35617954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Higher Prevalence of Venous Thromboembolism in the Hungarian Roma Population Could Be Due to Elevated Genetic Risk and Stronger Gene-Environmental Interactions.
    Natae SF; Kósa Z; Sándor J; Merzah MA; Bereczky Z; Pikó P; Ádány R; Fiatal S
    Front Cardiovasc Med; 2021; 8():647416. PubMed ID: 34765649
    [No Abstract]   [Full Text] [Related]  

  • 19. Asparaginase enzyme activity levels and toxicity in childhood acute lymphoblastic leukemia: a NOPHO ALL2008 study.
    Lynggaard LS; Rank CU; Hansen SN; Gottschalk Højfeldt S; Henriksen LT; Jarvis KB; Ranta S; Niinimäki R; Harila-Saari A; Wolthers BO; Frandsen TL; Heyman M; Schmiegelow K; Albertsen BK
    Blood Adv; 2022 Jan; 6(1):138-147. PubMed ID: 34625787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proportion of venous thromboembolism attributed to recognized prothrombotic genotypes in men and women.
    Løchen Arnesen CA; Evensen LH; Hveem K; Gabrielsen ME; Hansen JB; Brækkan SK
    Res Pract Thromb Haemost; 2024 Feb; 8(2):102343. PubMed ID: 38476459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.